Prostate Cancer News and Research

Latest Prostate Cancer News and Research

NCRI launches first virtual biobank for prostate cancer research

NCRI launches first virtual biobank for prostate cancer research

Pervasis receives $920,000 in grants under QTDP program

Pervasis receives $920,000 in grants under QTDP program

Amgen wins Scrip Best New Drug award for Prolia

Amgen wins Scrip Best New Drug award for Prolia

Radiotherapy can benefit men with high risk prostate cancer: Research

Radiotherapy can benefit men with high risk prostate cancer: Research

Onconome receives $231,000 cash grant under QTDP program

Onconome receives $231,000 cash grant under QTDP program

Synta reports $10.3M net loss for third quarter 2010 vs. $118.1M net income for third quarter 2009

Synta reports $10.3M net loss for third quarter 2010 vs. $118.1M net income for third quarter 2009

NWBT receives $490,000 in two grants under QTDP program

NWBT receives $490,000 in two grants under QTDP program

EUSA Pharma announces 10-year outcome data of PROSTASCINT in prostate cancer radiotherapy

EUSA Pharma announces 10-year outcome data of PROSTASCINT in prostate cancer radiotherapy

Level of prostate-specific protein after salvage radiation therapy predicts mortality and disease progression

Level of prostate-specific protein after salvage radiation therapy predicts mortality and disease progression

Gene fusion prostate cancers susceptible to secondary mutations

Gene fusion prostate cancers susceptible to secondary mutations

Millennium and Takeda initiate TAK-700 Phase III clinical trial in advanced prostate cancer

Millennium and Takeda initiate TAK-700 Phase III clinical trial in advanced prostate cancer

Medicare reimbursement cuts lead to decline in unnecessary or inappropriate care

Medicare reimbursement cuts lead to decline in unnecessary or inappropriate care

Top 10 Medical Innovations for 2011

Top 10 Medical Innovations for 2011

EUSA announces publication of PROSTASCINT imaging for prostate cancer in official journal of American Society

EUSA announces publication of PROSTASCINT imaging for prostate cancer in official journal of American Society

EUREKA program confirms ability of HIFU technology to deliver cancer drugs

EUREKA program confirms ability of HIFU technology to deliver cancer drugs

AHRQ study finds prostate cancer mortality rate declines by 45%

AHRQ study finds prostate cancer mortality rate declines by 45%

New technique could help scientists to predict how living prostate tissues respond to therapy

New technique could help scientists to predict how living prostate tissues respond to therapy

Image Guided IMRT preserves sexual function in men after prostatectomy

Image Guided IMRT preserves sexual function in men after prostatectomy

Quanterix granted $733,437 under QTDP program for Single Molecule Array platform

Quanterix granted $733,437 under QTDP program for Single Molecule Array platform

Staff member of U.S. preventive services task force quits over cancelled meeting

Staff member of U.S. preventive services task force quits over cancelled meeting

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.